97 related articles for article (PubMed ID: 11677781)
1. Proteome and glycosylation mapping identifies post-translational modifications associated with aggressive breast cancer.
Dwek MV; Ross HA; Leathem AJ
Proteomics; 2001 Jun; 1(6):756-62. PubMed ID: 11677781
[TBL] [Abstract][Full Text] [Related]
2. Expression of Helix pomatia lectin binding glycoproteins in women with breast cancer in relationship to their blood group phenotypes.
Welinder C; Jansson B; Ferno M; Olson H; Baldetorp B
J Proteome Res; 2009 Feb; 8(2):782-7. PubMed ID: 18998722
[TBL] [Abstract][Full Text] [Related]
3. The lectin Helix pomatia agglutinin recognizes O-GlcNAc containing glycoproteins in human breast cancer.
Rambaruth ND; Greenwell P; Dwek MV
Glycobiology; 2012 Jun; 22(6):839-48. PubMed ID: 22322011
[TBL] [Abstract][Full Text] [Related]
4. Helix pomatia agglutinin lectin-binding oligosaccharides of aggressive breast cancer.
Dwek MV; Ross HA; Streets AJ; Brooks SA; Adam E; Titcomb A; Woodside JV; Schumacher U; Leathem AJ
Int J Cancer; 2001 Mar; 95(2):79-85. PubMed ID: 11241316
[TBL] [Abstract][Full Text] [Related]
5. Immunolocalisation of members of the polypeptide N-acetylgalactosaminyl transferase (ppGalNAc-T) family is consistent with biologically relevant altered cell surface glycosylation in breast cancer.
Brooks SA; Carter TM; Bennett EP; Clausen H; Mandel U
Acta Histochem; 2007; 109(4):273-84. PubMed ID: 17448526
[TBL] [Abstract][Full Text] [Related]
6. A targeted glycoproteomic approach identifies cadherin-5 as a novel biomarker of metastatic breast cancer.
Fry SA; Sinclair J; Timms JF; Leathem AJ; Dwek MV
Cancer Lett; 2013 Jan; 328(2):335-44. PubMed ID: 23079531
[TBL] [Abstract][Full Text] [Related]
7. Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells.
Willipinski-Stapelfeldt B; Riethdorf S; Assmann V; Woelfle U; Rau T; Sauter G; Heukeshoven J; Pantel K
Clin Cancer Res; 2005 Nov; 11(22):8006-14. PubMed ID: 16299229
[TBL] [Abstract][Full Text] [Related]
8. Mass spectrometric analysis of high-mobility group proteins and their post-translational modifications in normal and cancerous human breast tissues.
Zou Y; Wang Y
J Proteome Res; 2007 Jun; 6(6):2304-14. PubMed ID: 17455969
[TBL] [Abstract][Full Text] [Related]
9. Proteome analysis of metastatic colorectal cancer cells recognized by the lectin Helix pomatia agglutinin (HPA).
Saint-Guirons J; Zeqiraj E; Schumacher U; Greenwell P; Dwek M
Proteomics; 2007 Nov; 7(22):4082-9. PubMed ID: 17994629
[TBL] [Abstract][Full Text] [Related]
10. Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence.
Holm NT; Byrnes K; Li BD; Turnage RH; Abreo F; Mathis JM; Chu QD
J Surg Res; 2007 Jul; 141(1):53-9. PubMed ID: 17574038
[TBL] [Abstract][Full Text] [Related]
11. Claudin-16 reduces the aggressive behavior of human breast cancer cells.
Martin TA; Harrison GM; Watkins G; Jiang WG
J Cell Biochem; 2008 Sep; 105(1):41-52. PubMed ID: 18442037
[TBL] [Abstract][Full Text] [Related]
12. Using a xenograft model of human breast cancer metastasis to find genes associated with clinically aggressive disease.
Kluger HM; Chelouche Lev D; Kluger Y; McCarthy MM; Kiriakova G; Camp RL; Rimm DL; Price JE
Cancer Res; 2005 Jul; 65(13):5578-87. PubMed ID: 15994930
[TBL] [Abstract][Full Text] [Related]
13. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
14. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
15. [Modification of glycoconjugates during the carcinogenesis: the case of mammary carcinomas].
Guillot J; Guerry M; Konska G; Caldefie-Chezet F; De Latour M; Penault-Llorca F
Bull Cancer; 2004 Feb; 91(2):141-58. PubMed ID: 15047454
[TBL] [Abstract][Full Text] [Related]
16. P7 antigen expression in human breast cancer.
Yang X; Groshen S; Formenti SC; Davidson NE; Press MF
Clin Cancer Res; 2003 Jan; 9(1):201-6. PubMed ID: 12538470
[TBL] [Abstract][Full Text] [Related]
17. The influence of N- and O-glycosylation inhibitors on the glycosylation profile of cellular membrane proteins and adhesive properties of carcinoma cell lines.
Paszkiewicz-Gadek A; Porowska H; Lemancewicz D; Wolczynski S; Gindzienski A
Int J Mol Med; 2006 Apr; 17(4):669-74. PubMed ID: 16525726
[TBL] [Abstract][Full Text] [Related]
18. Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo.
Bendre MS; Gaddy-Kurten D; Mon-Foote T; Akel NS; Skinner RA; Nicholas RW; Suva LJ
Cancer Res; 2002 Oct; 62(19):5571-9. PubMed ID: 12359770
[TBL] [Abstract][Full Text] [Related]
19. Ezrin silencing by small hairpin RNA reverses metastatic behaviors of human breast cancer cells.
Li Q; Wu M; Wang H; Xu G; Zhu T; Zhang Y; Liu P; Song A; Gang C; Han Z; Zhou J; Meng L; Lu Y; Wang S; Ma D
Cancer Lett; 2008 Mar; 261(1):55-63. PubMed ID: 18155831
[TBL] [Abstract][Full Text] [Related]
20. Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry.
Li DQ; Wang L; Fei F; Hou YF; Luo JM; ; Zeng R; Wu J; Lu JS; Di GH; Ou ZL; Xia QC; Shen ZZ; Shao ZM
Proteomics; 2006 Jun; 6(11):3352-68. PubMed ID: 16637015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
